Some news in the air
CEO is in town today.
https://www.finnewsnetwork.com.au/archives/finance_news_network394432.html
From the talk, you can see he is in Sydney in person.
And then the AIPAC003 is officially online.
https://www.clinicaltrials.gov/ct2/show/NCT05747794
I guess it would be the matter of time we hear the starting of that Ph2 component.
Note that this AIPAC003 is a total 849 patients ph2/3 trial. That is something Immutep is not handle by themselves. So there will be a partner or buy off the shelf event some time down the line.
And then Merck last night just announced officially the failure of Keynote-641 and Keynote-789, one aggressive prostate cancer and one NSCLC.
https://www.merck.com/news/merck-provides-update-on-phase-3-trials-keynote-641-and-keynote-789/
By far, Merck's superstar Keytruda is pretty much reaching the maximum capacity. These two are the last two trials that Keytruda combining with Chemo. So whatever Keytruda with/without Chemo can do, is all out there.
Keynote-789 failed? No worry, there is Keynote-798 (TACTI-002) just in your backyard.
I just don't know how much more data EFTI needs to feed in to trigger an event?
Some news in the air CEO is in town...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $480.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 32.0¢ | $1.703M | 5.215M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 211685 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 279000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |